FPHAX Holdings — Select Pharmaceuticals Portfolio
All 50 reported holdings of Select Pharmaceuticals Portfolio (FPHAX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| ELI LILLY and CO | 28.78% | $431.84M |
| Gsk PLC | 8.17% | $122.57M |
| Viatris, Inc. | 5.45% | $81.83M |
| Ucb SA | 5.09% | $76.36M |
| MERCK and CO INC | 4.74% | $71.15M |
| Roche Holding AG | 4.54% | $68.19M |
| Legend Biotech Corp. | 4.53% | $68.02M |
| Astrazeneca PLC | 4.22% | $63.38M |
| Elanco Animal Health, Inc. | 4.15% | $62.27M |
| Jazz Pharmaceuticals PLC | 4.09% | $61.39M |
| Gilead Sciences, Inc. | 3.97% | $59.53M |
| JOHNSON and JOHNSON | 3.77% | $56.60M |
| Royalty Pharma PLC | 2.67% | $40.09M |
| Fidelity Revere Street Trust | 2.44% | $36.65M |
| Moderna, Inc. | 1.57% | $23.56M |
| Intellia Therapeutics, Inc. | 1.19% | $17.82M |
| Beam Therapeutics, Inc. | 1.10% | $16.48M |
| Axsome Therapeutics, Inc. | 1.08% | $16.18M |
| Biontech SE | 1.04% | $15.66M |
| Xenon Pharmaceuticals, Inc. | 0.82% | $12.37M |
| Ocular Therapeutix, Inc. | 0.80% | $12.00M |
| Idexx Laboratories, Inc. | 0.61% | $9.13M |
| Swedish Orphan Biovitrum Ab | 0.54% | $8.15M |
| Ptc Therapeutics, Inc. | 0.54% | $8.12M |
| Capricor Therapeutics, Inc. | 0.46% | $6.93M |
| Kymera Therapeutics, Inc. | 0.46% | $6.88M |
| Raia Drogasil SA | 0.42% | $6.27M |
| Annexon, Inc. | 0.36% | $5.44M |
| Arrowhead Pharmaceuticals, Inc. | 0.34% | $5.10M |
| Harmony Biosciences Holdings, Inc. | 0.33% | $5.01M |
| Serif Biomedicines, Inc. | 0.33% | $5.00M |
| Crinetics Pharmaceuticals, Inc. | 0.31% | $4.67M |
| Definium Therapeutics, Inc. | 0.30% | $4.55M |
| Corcept Therapeutics, Inc. | 0.29% | $4.33M |
| Uniqure N.v. | 0.28% | $4.20M |
| Ascendis Pharma A/s | 0.27% | $4.10M |
| Agomab Therapeutics SA | 0.25% | $3.74M |
| Disc Medicine, Inc. | 0.25% | $3.74M |
| Amylyx Pharmaceuticals, Inc. | 0.25% | $3.70M |
| Phibro Animal Health Corp. | 0.20% | $3.07M |
| Ionis Pharmaceuticals, Inc. | 0.20% | $3.07M |
| Edgewise Therapeutics, Inc. | 0.19% | $2.86M |
| Paragon Biosciences Emalex Capital, Inc. | 0.19% | $2.79M |
| Fidelity Revere Street Trust | 0.17% | $2.59M |
| Evozyne, Inc. | 0.15% | $2.26M |
| Castle Creek Biosciences, Inc. | 0.10% | $1.48M |
| Kailera Therapeutics, Inc. | 0.01% | $206.46K |
| Agomab Therapeutics SA | 0.01% | $102.38K |
| Myos Corp. | 0.00% | $50.00K |
| Medavail Holdings, Inc. | 0.00% | $0 |
FPHAX overview: performance, fees, allocation and SEC filings